alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report ofGenesco Inc. (the “Company”) on Form 10-K for the period ended January 28, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert J. Dennis, Chief Executive Officer of theCompany, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

/s/ Robert J.Dennis                                                 

Robert J. Dennis 

Chief Executive Officer 

March 28, 2012
EXHIBIT 32.b



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Boston Capital Tax Credit Fund III L.P. (the "Fund") on Form 10-Q for the period ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Marc N. Teal, Principal Financial Officer of the general partner of the general partner of the Fund's general partner, C&M Management Inc., certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:



|(1) | The Report fully complies with the requirements of section 13(a)-15 or 15(d)-15 of the Securities and Exchange Act of 1934; and                  
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                  
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Fund.



|Date:           |  |                            
|--------------- |  | ---------------------------
|August 14, 2009 |  | /s/ Marc N. Teal           
|                |  |                            
|                |  | Marc. N. Teal              
|                |  | Principal Financial Officer



A signed original of this written statement required by Section 906, or other

document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET OF FINANCIAL FEDERAL CORPORATION AND SUBSIDIARIES
AT JULY 31, 1999 AND THE RELATED CONSOLIDATED STATEMENT OF OPERATIONS FOR
THE YEAR THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUL-31-1999
<PERIOD-END>                               JUL-31-1999
<CASH>                                            5544
<SECURITIES>                                         0
<RECEIVABLES>                                   948727
<ALLOWANCES>                                     16202
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  942185
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                         745442
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                          7430
<OTHER-SE>                                      137552
<TOTAL-LIABILITY-AND-EQUITY>                    942185
<SALES>                                              0
<TOTAL-REVENUES>                                 89118
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                  3100
<INTEREST-EXPENSE>                               39169
<INCOME-PRETAX>                                  36829
<INCOME-TAX>                                     14231
<INCOME-CONTINUING>                              22598
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     22598
<EPS-BASIC>                                     1.52
<EPS-DILUTED>                                     1.30
<FN>
THE FINANCIAL STATEMENTS INCLUDE AN UNCLASSIFIED BALANCE SHEET.
</FN>


</TABLE>
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markman

Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 _________________________________________

 Clerk

June 25, 2012

h0618

Order 

June 25, 2012

144462

QUALITY ONE CONSTRUCTION &

DEVELOPMENT, INC.,

Plaintiff-Appellant,

v SC: 144462

COA: 303674

Wayne CC: 10-010696-AS

CITY OF DEARBORN,

Defendant-Appellee.

____________________________________/

On order of the Court, the application for leave to appeal the December 15, 2011 

order of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the question presented should be reviewed by this Court.
IV 

114TH CONGRESS 

1ST SESSION H. RES. 222 

Expressing the sense of the House of Representatives that any resolution 

to the Israeli-Palestinian conflict should come from direct bilateral negotiations without preconditions and without interference from the United 

Nations. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 28, 2015 

Mr. MCKINLEY (for himself, Mr. LAMBORN, Mr. WEBER of Texas, and Mr. 

JOHNSON of Ohio) submitted the following resolution; which was referred 

to the Committee on Foreign Affairs 

RESOLUTION 

Expressing the sense of the House of Representatives that 

any resolution to the Israeli-Palestinian conflict should 

come from direct bilateral negotiations without preconditions and without interference from the United Nations. 

Whereas it has been longstanding policy of the United States 

under both Democratic and Republican Administrations 

and Congresses that a durable resolution to the IsraeliPalestinian conflict can be achieved only through direct 

negotiations between two parties without preconditions; 

Whereas it has been longstanding policy of the United States 

under both Democratic and Republican Administrations 

and Congresses to promote a resolution to the IsraeliVerDate Sep 11 2014 02:05 Apr 29, 2015 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR222.IH HR222

emcdonald on DSK67QTVN1PROD with BILLS
2 

•HRES 222 IH 

Palestinian conflict through direct negotiations between 

the two parties; 

Whereas both Democratic and Republican-led Congresses 

have long appropriated funds to promote a resolution to 

the Israeli-Palestinian conflict through direct negotiations 

between the two parties; 

Whereas it has been the longstanding policy of the United 

States under both Democratic and Republican Administrations and Congresses that a United Nations mandate 

to force a final status agreement to the Israeli-Palestinian peace process is harmful and not appropriate; and 

Whereas this Congress would view any support by the United 

States Government for a United Nations effort to dictate 

conditions, details, or timelines for negotiations and a 

resolution between Israel and the Palestinian Authority 

as a violation of long-standing and sound United States 

policy: Now, therefore, be it 

1 Resolved, That it is the sense of the United States 

2 House of Representatives that a resolution to the Israeli3 Palestinian conflict should come from direct bilateral ne4 gotiations without preconditions and without interference 

5 from the United Nations. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
```

[Federal Register: February 24, 2010 (Volume 75, Number 36)]
[Notices]               
[Page 8309-8310]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24fe10-37]                         

=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION

 
Sunshine Act Meetings

Time and Date: Wednesday, February 24, 2010, 2 p.m.-4 p.m.

Place: Hearing Room 420, Bethesda Towers, 4330 East West Highway, 
Bethesda, Maryland.

Status: Closed to the Public.

Matter To Be Considered: 

Compliance Weekly/Monthly Report--Commission Briefing

    The staff will brief the Commission on various compliance matters.
    For a recorded message containing the latest agenda information, 
call (301) 504-7948.

[[Page 8310]]


Contact Person for More Information: Todd A. Stevenson, Office of the 
Secretary, U.S. Consumer Product Safety Commission, 4330 East West 
Highway, Bethesda, MD 20814. (301) 504-7923.

    Dated: February 16, 2010.
Todd A. Stevenson,
Secretary.
[FR Doc. 2010-3515 Filed 2-23-10; 8:45 am]
BILLING CODE 6355-01-M
```
2

Sincerely,
cc: Hon. Lidia Stiglich, District Judge 

Washoe County Public Defender 

Attorney General/Carson City 

Washoe County District Attorney 

Washoe District Court Clerk 

Walter William Bulkeley 

SUPREME COURT 

OF 

NEVADA 

(0) 1947A 

2 

MIME kalE111111111
#### State v. Chun Fat

23597

03/19/2002

Affirmed
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 84346)    
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel;  Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity.                    

*Date:*                         February 27, 2024.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, NIDDK Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Michele L. Barnard, Ph.D. Scientific Review Officer, Review Branch, Division of Extramural Activities, NIDDK, National Institutes of Health, Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 594-8898,                         *barnardm@extra.niddk.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: November 29, 2023.

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-26632 Filed 12-4-23; 8:45 am]

BILLING CODE 4140-01-P
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in Local Rule 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 96-10660 Conference Calendar

DENNIS R. PADEN, Plaintiff-Appellant,

versus KATHLEEN HAWK, Director, BOP; CHARLES TURNBO, Regional Director, BOP; JOHN DOE, Safety Manager FMC Fort Worth; CURTIS MILLS, Electrical Foreman FMC, Fort Worth; GEORGE E. KILLINGER, Warden, FCI Ft. Worth, Defendants-Appellees.

- - - - - - - - - - - Appeal from the United States District Court for the Northern District of Texas USDC No. 4:95-CV-917-A

- - - - - - - - - - - - August 22, 1996 Before KING, DUHÉ, and DeMOSS, Circuit Judges.
PER CURIAM: * Dennis Paden, #47044-079, appeals from summary judgment in favor of the defendants. Appellees have filed a motion to dismiss this appeal pursuant to 5th Cir. R. 42.2 because it is frivolous. Appellees argue that the district court did not errNo. 96-10660 - 2 - in granting summary judgment, dismissing appellant’s civil rights action filed pursuant to Bivens v. Six Unknown Named Agents of Fed. Bureau of Narcotics , 403 U.S. 388 (1971). The defendantsappellees met their initial burden of showing that there was no genuine issue. Fed. R. Civ. P. 56(e). The burden shifted to appellant to set forth specific facts showing the existence of a genuine issue for trial. Paden’s conclusional allegations and unsubstantiated assertions failed to satisfy this burden. Little v. Liquid Air Corp. , 37 F.3d 1069, 1075 (5th Cir. 1994) (en banc). Therefore, the district court did not err in granting summary judgment. Appellant’s brief, which repeats these conclusional allegations and unsubstantiated assertions, is frivolous. Accordingly, we GRANT appellee’s motion to dismiss the appeal pursuant to 5th Cir. R. 42.2. We caution Paden that any additional frivolous appeals filed by him will invite the imposition of sanctions. To avoid sanctions, Paden is further cautioned to review any pending appeals to ensure that they do not raise arguments that are frivolous.
APPEAL DISMISSED. SANCTION WARNING ISSUED.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997             DEC-31-1996
<PERIOD-START>                             JAN-01-1997             JAN-01-1996
<PERIOD-END>                               MAR-31-1997             MAR-31-1996
<CASH>                                         608,754                 164,118
<SECURITIES>                                         0                       0
<RECEIVABLES>                                3,774,051               4,605,632
<ALLOWANCES>                                         0                       0
<INVENTORY>                                  5,499,754               5,974,719
<CURRENT-ASSETS>                            11,146,573              11,493,165
<PP&E>                                      13,708,941              13,100,850
<DEPRECIATION>                              (1,635,568)             (1,271,270)
<TOTAL-ASSETS>                              37,531,706              37,775,942
<CURRENT-LIABILITIES>                       19,255,741              19,589,651
<BONDS>                                     14,589,641              13,442,197
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                        76,866                  72,583
<OTHER-SE>                                       4,479               1,067,216
<TOTAL-LIABILITY-AND-EQUITY>                37,531,706              37,775,942
<SALES>                                     11,818,104              10,059,001
<TOTAL-REVENUES>                            11,818,104              10,059,001
<CGS>                                        8,383,879               6,558,249
<TOTAL-COSTS>                               13,704,944              10,970,805
<OTHER-EXPENSES>                                13,549                  27,712
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                           1,703,313                 306,476
<INCOME-PRETAX>                             (3,603,702)             (1,245,992)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                         (3,603,702)             (1,245,992)
<DISCONTINUED>                                       0                (32,000)
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                (3,603,702)             (1,277,992)
<EPS-PRIMARY>                                     (.49)                   (.21)
<EPS-DILUTED>                                     (.49)                   (.21)
        

</TABLE>
Annex 4: Item 4.2

**USA COMMENTS**

CHAPTER 1.3.**DISEASES LISTED BY THE OIE**

[...]

Article 1.3.3.

The following *diseases* of crustaceans are listed by the OIE:

‒	Acute hepatopancreatic necrosis disease

‒	Infection with *Aphanomyces**astaci* (crayfish plague)

‒	Infection with *Hepatobacter**penaei* (necrotising hepatopancreatitis)

‒	Infection with infectious hypodermal and haematopoietic necrosis virus

‒	Infection with infectious myonecrosis virus

‒	Infection with *Macrobrachium**rosenbergii* nodavirus (white tail disease)

‒	Infection with decapod iridescent virus 1

**General comment:** We support the listing of DIV1 due to the potential risks for international trade; however, a concern regarding diagnostic testing of DIV1 is the availability and access to the necessary positive control materials. We look forward to the continued review and consideration of the ad hoc group(s) concerning this issue of diagnostic capacity.

‒	Infection with Taura syndrome virus

‒	Infection with white spot syndrome virus

‒	Infection with yellow head virus genotype 1
According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it 

displays a valid OMB control number. The valid OMB control number for this information collection is 0579-0013. The time required to complete this information collection is 

estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and 

completing and reviewing the collection of information.

OMB Approved 

0579-0013 

EXP: 02/2022

This report is required to determine if tests conducted on each serial and each subserial are satisfactory prior to release of the serial or subserial (9 CFR 116)

U.S. DEPARTMENT OF AGRICULTURE

ANIMAL AND PLANT HEALTH INSPECTION SERVICE

CONTINUATION FOR VETERINARY BIOLOGICS PRODUCTION AND TEST REPORT

1. PAGE

OF

NOTE: Submit an original and one copy for every serial or subserial which reaches any stage of identification and 

testing.

2. LICENSE OR PERMIT NUMBER

3. NAME OF LICENSEE OR PERMITTEE 4. PRODUCT CODE NUMBER

5. PRODUCING SUBSIDIARY 6. SERIAL OR SUBSERIAL NUMBER

7. TRUE NAME OF PRODUCT

8. TEST DATA

TEST

REFERENCE

(A)

TEST DATES

RESULTS

(D)

INSERT CODE

S - SATISFACTORY U - UNSATISFACTORY 

I - INCONCLUSIVE NT - NO TEST (E)

STARTED

(B)

CONCLUDED

(C)

9. REMARKS

10. SIGNATURE (Authorized Firm Representative) 11. TITLE 12. DATE

APHIS FORM 2008A Previous editions are obsolete.

MAY 2016
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Animals and Animal Products - Code

of Federal Regulations

Last Modified: 

Print

Regulations are codified annually in the U.S. Code of Federal Regulations (CFR). The

CFR annual edition is the codification of the general and permanent rules published

in the Federal Register by the departments and agencies of the Federal

Government. Please note, Title 9 of the CFR is not typically updated until April of the

current calendar year.

For a currently updated version of the Code of Federal Regulations (CFR),

you may visit the Electronic Code of Federal Regulations (e-CFR). While it is

not an official legal edition of the CFR, the e-CFR is an editorial compilation of CFR

material and Federal Register amendments produced by the National Archives and

Records Administration's Office of the Federal Register (OFR) and the Government

Publishing Office. The OFR updates the material in the e-CFR on a daily basis. The

current update status appears at the top of all e-CFR web pages.

Title 9 - Animals and Animal Products

Chapter I - Animal and Plant Health inspection Service, 

Department of Agriculture

Subchapter E - VIRUSES, SERUMS, TOXINS, AND ANALOGOUS

PRODUCTS; ORGANISMS AND VECTORS

Parts 101 to 124
as of January 1, 2021

Part Description

101 Definitions

102 Licenses for biological products

103

Experimental production, distribution, and evaluation of biological products

prior to licensing

104 Permits for biological products

105 Suspension, revocation, or termination of biological licenses or permits

106

Exemption for biological products used in department programs or under

department control or supervision

107

Exemptions from preparation pursuant to an unsuspended and unrevoked

license

108 Facility requirements for licensed establishments

109 Sterilization and pasteurization at licensed establishments

112 Packaging and labeling

113 Standard requirements

114 Production requirements for biological products

115 Inspections

116 Records and reports

117 Animals at licensed establishment

118 Detention; seizure and condemnation

121 Possession, use, and transfer of biological agents and toxins

122 Organisms and vectors

123 Rules of practice governing proceedings under the Virus-Serum-Toxin Act